Bibliography
Export 17 results:
Filters: Author is Strong,D. M. and Keyword is Humans [Clear All Filters]
Organ and tissue safety workshop 2007: advances and challenges. Cell Tissue Bank. 2009;10(3):271-80.
Donor derived malignancy following transplantation: a review. Cell Tissue Bank. 2007;8(4):267-86.
Human tissue oversight in hospitals: an AABB survey. Transfusion. 2007;47(2):194-200.
Cardiovascular tissues for transplantation. Clin Lab Med. 2005;25(3):571-85.
A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion. 2005;45(2):254-64.
Preventing disease transmission by deceased tissue donors by testing blood for viral nucleic acid. Cell Tissue Bank. 2005;6(4):255-62.
Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N Engl J Med. 2004;351(8):751-9.
Blood-bank testing for infectious diseases: how safe is blood transfusion? Trends Mol Med. 2002;8(7):355-8.
Effect of storage and preservation methods on viability in transplantable human skin allografts. Burns. 2000;26(4):367-78.
Long-term follow-up of patients with osteochondral allografts. A correlation between immunologic responses and clinical outcome. Orthop Clin North Am. 1999;30(4):583-8.
Immunologic responses in human recipients of osseous and osteochondral allografts. Clin Orthop Relat Res. 1996;(326):107-14.
Transmission of the hepatitis-C virus by tissue transplantation. J Bone Joint Surg Am. 1995;77(2):214-24.
The effects of freeze-drying and rehydration on cancellous bone. Clin Orthop Relat Res. 1993;(290):279-84.
Studies on the antigenicity of bone. II. Donor-specific anti-HLA antibodies in human recipients of freeze-dried allografts. J Bone Joint Surg Am. 1984;66(1):107-12.
Bone allograft antigenicity in an experimental model and in man. Acta Med Pol. 1978;19(40575):197-205.
Cellular immunity to cytomegalovirus in a patient following bone marrow transplantation. Transplantation. 1978;26(2):99-102.